Summary Wockhardt Limited (Wockhardt) is a pharmaceutical and biotechnology company that manufactures and markets vaccines, active pharmaceutical ingredients (APIs), pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes, among others. Wockhardt also holds expertise in biotechnology research with a focus on gene cloning; development of production strains and expression of proteins. It also focuses its research in generics, novel drug delivery system; and new chemical entities. The company operates along with its subsidiaries in India, the UK, Switzerland and British Virgin Islands. Wockhardt is headquartered in Mumbai, Maharashtra, India. Wockhardt Limited (WOCKPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on... Research Beam Model: Research Beam Product ID: 549325 250 USD New
Wockhardt Limited (WOCKPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Wockhardt Limited (WOCKPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : March   2016
  • Pages : 21
  • Publisher : GlobalData
 
 
 
Summary

Wockhardt Limited (Wockhardt) is a pharmaceutical and biotechnology company that manufactures and markets vaccines, active pharmaceutical ingredients (APIs), pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes, among others. Wockhardt also holds expertise in biotechnology research with a focus on gene cloning; development of production strains and expression of proteins. It also focuses its research in generics, novel drug delivery system; and new chemical entities. The company operates along with its subsidiaries in India, the UK, Switzerland and British Virgin Islands. Wockhardt is headquartered in Mumbai, Maharashtra, India.

Wockhardt Limited (WOCKPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Wockhardt Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Wockhardt Limited, Medical Devices Deals, 2010 to YTD 2016 8
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Wockhardt Limited, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sheffield Bio-Science Enters Into Collaboration With Wockhardt 10
Equity Offering 11
Wockhardt Bio Completes IPO For US$2.5 Million 11
Asset Transactions 12
Danone Completes Acquisition Of Nutrition Business Of Wockhardt For US$228 Million 12
Acquisition 14
Genopharm Acquires Girex And Mazal From Wockhardt 14
Abbott Labs Terminates Acquisition Of Carol Info Services And Related Nutrition Subsidiaries From Wockhardt 15
Wockhardt Limited - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables
List of Tables
Wockhardt Limited, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Wockhardt Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Wockhardt Limited, Medical Devices Deals, 2010 to YTD 2016 8
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Sheffield Bio-Science Enters Into Collaboration With Wockhardt 10
Wockhardt Bio Completes IPO For US$2.5 Million 11
Danone Completes Acquisition Of Nutrition Business Of Wockhardt For US$228 Million 12
Genopharm Acquires Girex And Mazal From Wockhardt 14
Abbott Labs Terminates Acquisition Of Carol Info Services And Related Nutrition Subsidiaries From Wockhardt 15
Wockhardt Limited, Key Competitors 17
Wockhardt Limited, Key Employees 18
Wockhardt Limited, Other Locations 19
Wockhardt Limited, Subsidiaries 20

List Of Figures
List of Figures
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Wockhardt Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Wockhardt Limited, Medical Devices Deals, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter